Author:
Singh Rajeeva,Erickson Hans K.
Reference29 articles.
1. Ricart, A. D., and Tolcher, A. W. (2007) Technology insight: cytotoxic drug immunoconjugates for cancer therapy. Nat. Clin. Pract. Oncol., 4, 245–255.
2. Chari., R. V. J. (2008) Targeted cancer therapy: conferring specificity to cytotoxic drugs. Accounts Chem. Res., 41, 98–107.
3. Lambert, J. M. (2005) Drug-conjugated monoclonal antibodies for the treatment of cancer. Curr. Opin. Pharmacol., 5, 543–549.
4. Wu, A. M., and Senter, P. D. (2005) Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol., 23, 1137–1146.
5. Hamann, P. R., Hinman, L. M., Beyer, C. F., et al. (2002) An anti-CD33 antibody–calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker. Bioconjugate Chem., 13, 4046.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献